What is AXIOFILL? AXIOFILL ® is a biocompatible acellular human placental Extracellular Matrix (ECM) derived from the placental disc. It is intended for use in the replacement or supplementation of …

Jan 10, 2024 · The agency asked MiMedx to respond within 15 working days of receiving the letter. MiMedx launched Axiofill in September 2022 for use in large, complex wounds and those of irregular …

Mar 27, 2024 · Based on this precedent, MIMEDX introduced AXIOFILL in September 2022, also as a 361 product. As we now know, the FDA has taken a position that AXIOFILL is designated as a 351 …

This is "AXIOFILL Application Guide" by MIMEDX on Vimeo, the home for high quality videos and the people who love them.

AxioFill is a lyophilized placental connective tissue matrix that supports healing of chronic and acute foot and ankle wounds. Its natural scaffold aids in granulation and tissue regeneration.

AXIOFILL® is a biocompatible acellular human placental extracellular matrix (ECM) derived from the placental disc. It is intended for use in the replacement or supplementation of damaged or …

AXIOFILL is a biocompatible acellular human placental extracellular matrix (ECM) derived from the placental disc. It is intended for use in the replacement or supplementation of damaged or …

Sep 20, 2022 · AXIOFILL provides a cost-effective human collagen scaffold that is conducive for use in large, complex wounds and those of irregular geometries. It may be applied directly as a dry …

To create a paste with AXIOFILL, slowly mix 1.5 mL of sterile saline solution for every 250 mg of the particulate (Figure 4). Using more or less solution will produce a thinner or thicker consistency. Cover …

Mar 27, 2024 · MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has issued a determination letter in connection …